Skip to content

Artificial intelligence-assisted system for diagnosing precancerous lesions and superficial esophageal squamous cell carcinoma

Artificial intelligence-assisted system for diagnosing precancerous lesions and superficial esophageal squamous cell carcinoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052116
Enrollment
Unknown
Registered
2021-10-19
Start date
2021-10-19
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precancerous lesions and superficial esophageal squamous cell carcinoma

Interventions

Gold Standard:Upper gastrointestinal endoscopy examination and the results diagnosed by endoscopists combined with pathology
Index test:The&#32
miss&#32
rate&#32
of&#32
or&#32
cell&#32
carcinoma
&#32
The&#32
detection&#32

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing painless gastroscopy screening or previous painless gastroscopy review after upper gastrointestinal endoscopic resection; 2. Those aged >=18 years old.

Exclusion criteria

Exclusion criteria: 1. Clearly advanced esophageal cancer; 2. Those who had previous esophageal surgery; 3. Those who have contraindications to biopsy or refuse biopsy; 4. Known active upper gastrointestinal bleeding or emergency endoscopy; 5. Esophageal stricture; 6. Those who are pregnant; 7. Those who have not completed the first gastroscopy; 8. Those who have not completed the second gastroscopy; 9. Patients with repeated examinations; 10. Refuse to participate in the researcher.

Design outcomes

Primary

MeasureTime frame
The miss rate of precancerous lesions or superficial esophageal squamous cell carcinoma;

Secondary

MeasureTime frame
The detection rate precancerous lesions or superficial esophageal squamous cell carcinoma;The biopsy rate;Number of precancerous lesions or superficial esophageal squamous cell carcinoma per patient;Inspection time;Adverse events;

Countries

China

Contacts

Public ContactHu Bing

West China Hospital, Sichuan University

hubingnj@163.com+86 18980601278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026